362 results on '"Palou, Juan"'
Search Results
2. Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma
3. Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
4. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
5. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis
6. Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer
7. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
8. Reply by Authors
9. New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details
10. Impact of Synchronous Metastasis Distribution on Cancer Specific Survival in Renal Cell Carcinoma after Radical Nephrectomy with Tumor Thrombectomy
11. Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer
12. Neisseria meningitidis y el aumento del sexo oral. A propósito de un caso
13. Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer
14. Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus
15. Corrigendum to “Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis” [Eur Urol Oncol 2021;4:927–42]
16. Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): A Randomised Controlled Study
17. Laparoscopic Radical Nephroureterectomy for Upper Tract Transitional Cell Carcinoma
18. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population
19. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
20. Clinical Predictive Factors of Poor Outcome in Patients With Stage pT0 Disease at Radical Cystectomy
21. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
22. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence
23. IMPACT OF SURGICAL VOLUME ON PERIOPERATIVE OUTCOMES AFTER NEPHRECTOMY WITH TUMOR THROMBECTOMY: MP64-13
24. SALVAGE RADICAL PROSTATECTOMY COMPLICATIONS AND FUNCTIONAL OUTCOMES: OPEN VERSUS ROBOTIC PROCEDURES.: MP50-03
25. COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES: PD12-12
26. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?
27. Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis
28. Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study
29. MP44-17 THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC)
30. V5-09 3-MM LAPAROSCOPIC OFF-CLAMP RENAL TUMORECTOMY USING HYDRODISSECTION
31. V5-07 OFF-CLAMP LAPAROSCOPIC PARTIAL NEPHRECTOMY IN A HORSESHOE KIDNEY
32. V5-06 3 MM OFF-CLAMP PARTIAL NEPHRECTOMY: PROS, CONS, TIPS AND TRICKS
33. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives
34. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections
35. Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors
36. Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study
37. Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy
38. Intravesical Chemotherapy and BCG for the Treatment of Bladder Cancer: Evidence and Opinion
39. PROGRESSION TO MUSCLE INVASIVE DISEASE OF G1-2/LOW GRADE NON-MUSCLE INVASIVE BLADDER CANCER: NEVER AT THE FIRST RECURRENCE: MP65-18
40. DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS: MP57-11
41. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis
42. Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]
43. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees
44. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multistakeholder effort† EU*ACME: under the auspices of the EAU-ESMO guidelines committees
45. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative Multistakeholder effort: under the auspices of the EAU-ESMO Guidelines Committees
46. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort †[Formula presented] : Under the Auspices of the EAU-ESMO Guidelines Committees
47. AU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort : Under the Auspices of the EAU-ESMO Guidelines Committees
48. Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy : factors associated to hospitalization and treatment strategies
49. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees
50. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort:Under the Auspices of the EAU-ESMO Guidelines Committees
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.